Figure 2
Obesity prevalence in 22q11.2DS compared with Canadian norms. Bar graph illustrating the obesity prevalence in 22q11.2DS, with (light grey) and without (medium grey bar) history of antipsychotic use, compared with the reported obesity prevalence in the general Canadian population (dark grey bar).16 Error bars represent 95% confidence intervals calculated based on a study by Richardson et al.15 or as provided for Canadian norms.16 Also displayed are data for the two age groups reported by Statistics Canada,16 (i.e., 18-19 years and 20-34 years of age) where the number of subjects was >20 for the 22q11.2DS subgroups, with or without antipsychotic use.
